• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Substance Use Disorders (SUD)

Bicycle Health Raises $16.5M to Scale Virtual Opioid Use Disorder Treatment

by Fred Pennic 01/29/2025 Leave a Comment

Bicycle Health Raises $16.5M to Scale Virtual Opioid Use Disorder Treatment

What You Should Know:  - Bicycle Health, the nation's largest provider of virtual opioid use disorder (OUD) treatment, today announced a $16.5 million funding round led by Questa Capital, with participation from all existing and new investor JSL Health.  - The investment comes on the heels of Bicycle Health achieving operating profitability in 2024, demonstrating the company's commitment to sustainable growth while addressing the ongoing opioid epidemic. Addressing a Critical
Read More

Eleos Secures $60M to Expand AI-Powered Behavioral Health Solutions and Tackle SUD Crisis

by Fred Pennic 01/22/2025 Leave a Comment

Eleos Secures $60M to Expand AI-Powered Behavioral Health Solutions and Tackle SUD Crisis

What You Should Know:  - Eleos Health, a pioneer in AI-driven solutions for behavioral health secures $60M in Series C funding round led by Greenfield Partners. The funding round includes participation from existing investors such as F-Prime Capital, Eight Roads, Menlo Ventures, and ION, as well as new investors like the Michael & Susan Dell Foundation, Union Tech Ventures, and Centerstone. - The latest investment brings Eleos' total funding to over $120M and underscores the
Read More

Magellan Health Launches First FDA-Approved Prescription Digital Therapeutic

by HITC Staff 01/17/2018 Leave a Comment

magellanhealth

Magellan Health has announced the launch of reSET therapy, a pilot initiative using the first-ever FDA cleared prescription digital therapeutic from PEAR Therapeutics to improve outcomes for individuals struggling with Substance Use Disorders (SUD) and other related conditions.With the current challenges in our nation related to substance use, the evidence-based, non-drug treatment option presented with this approach is an opportunity to offer a practical solution to meet these complex needs and
Read More

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Evernorth Health Services Invests $3.5B in Shields Health Solutions

Evernorth Health Services Invests $3.5B in Shields Health Solutions

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

Sage Growth Partners Report: Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |